Published in J Clin Aesthet Dermatol on September 01, 2010
A new surgical method for penile girth enhancement. Int J Clin Exp Med (2015) 0.75
Petroleum jelly-induced penile paraffinoma with inguinal lymphadenitis mimicking incarcerated inguinal hernia. Can Urol Assoc J (2012) 0.75
Sinonasal myospherulosis and paraffin retention cysts suggested by CT: report of a case. Head Neck Pathol (2011) 0.75
Penile paraffinoma: self-injection with mineral oil. J Am Acad Dermatol (2002) 1.18
Sclerosing lipogranuloma of the genitalia treated with corticosteroids. Int Urol Nephrol (2006) 1.16
Debilitating silicone granuloma of the penis and scrotum. Ann Plast Surg (1995) 1.14
Treatment and outcome of vaseline-induced sclerosing lipogranuloma of the penis. Urology (2008) 1.11
A new repair technique for penile paraffinoma: bilateral scrotal flaps. Ann Plast Surg (1996) 1.10
Sexual function and psychological characteristics of penile paraffinoma. Asian J Androl (2003) 1.10
Mineral oil granuloma of the penis. J Eur Acad Dermatol Venereol (2003) 1.01
Subcutaneous cod liver oil injection for penile augmentation: review of literature and report of eight cases. Urology (2010) 1.00
Paraffinoma of the external genitalia after autoinjection of vaseline. Eur Urol (2000) 0.98
The effects of penile girth enhancement using injectable hyaluronic acid gel, a filler. J Sex Med (2010) 0.95
Penile paraffinoma. J Eur Acad Dermatol Venereol (2003) 0.93
Subcutaneous metallic mercury injection for penile augmentation. Urology (2007) 0.90
Augmentation phalloplasty. Urol Clin North Am (1995) 0.87
Silicone pneumonitis after a cosmetic augmentation procedure. N Engl J Med (2006) 0.87
Petroleum jelly lipogranuloma of the penis treated with excision and native skin coverage. Urology (2000) 0.86
Sclerosing lipogranuloma of the penis. A case report. Int Urol Nephrol (1991) 0.84
Phalloplasty and penile implant surgery. Curr Urol Rep (2009) 0.83
Silicone-induced penile sclerosing lipogranuloma. J Urol (1973) 0.83
Lung embolism with liquid silicone. J Forensic Sci (1989) 0.80
Penile paraffinoma and a novel treatment. BJU Int (2003) 0.79
Lipogranulomata of male genitalia. Br J Urol (1967) 0.79
Causative pathogens, antibiotic sensitivity, resistance patterns, and severity in a contemporary series of Fournier's gangrene. Urology (2013) 2.86
Bicycle-related genitourinary injuries. Urology (2011) 2.35
Vitamin D deficiency predicts prostate biopsy outcomes. Clin Cancer Res (2014) 1.65
Outcomes in geriatric genitourinary trauma. J Am Coll Surg (2011) 1.60
Pediatric genital injury: an analysis of the National Electronic Injury Surveillance System. Urology (2013) 1.52
Prudent diet and preventive nutrition from pediatrics to geriatrics: current knowledge and practical recommendations. Indian Heart J (2003) 1.43
Is routine postoperative chest radiography needed after percutaneous nephrolithotomy? Urology (2011) 1.43
Clinical outcomes of nonoperative management in emphysematous urinary tract infections. Urology (2012) 1.09
Combined living-related segmental liver and bowel transplantation for megacystis-microcolon-intestinal hypoperistalsis syndrome. J Pediatr Surg (2008) 1.08
More on robot-assisted laparoscopic radical cystectomy. N Engl J Med (2014) 1.06
Predictors of serum vitamin D levels in African American and European American men in Chicago. Am J Mens Health (2012) 0.96
Smoking cessation assistance for patients with bladder cancer: a national survey of American urologists. J Urol (2010) 0.95
Magnetic resonance imaging-directed transrectal ultrasonography-guided biopsies in patients at risk of prostate cancer. BJU Int (2007) 0.93
Chronic prostatitis: management strategies. Drugs (2009) 0.92
Recurrent giant cell carcinoma of the bladder. J Urol (2002) 0.90
Clinical characteristics and surgical outcomes of penetrating external genital injuries. J Trauma Acute Care Surg (2013) 0.89
The use of muscle flaps for the management of recalcitrant gastrointestinal fistulas. Clin Plast Surg (2006) 0.89
Common vitamin D pathway gene variants reveal contrasting effects on serum vitamin D levels in African Americans and European Americans. Hum Genet (2014) 0.88
Smoking and prostate cancer in a multi-ethnic cohort. Prostate (2013) 0.87
In LNCaP cells enhanced expression of the androgen receptor compensates for Bcl-2 suppression by antisense oligonucleotides. Ther Adv Urol (2011) 0.84
Effects of BCL-2 suppression by antisense oligonucleotides on additional regulators of apoptosis compensatory change in non-targeted protein expression. In Vivo (2011) 0.81
Brief smoking cessation intervention: a prospective trial in the urology setting. J Urol (2012) 0.80
Differentiated prostatic antigen expression in LNCaP cells following treatment with bispecific antisense oligonucleotides directed against BCL-2 and EGFR. Med Oncol (2011) 0.80
Ethnicity and smoking status are associated with awareness of smoking related genitourinary diseases. J Urol (2012) 0.80
Bax expression remains unchanged following antisense treatment directed against BCL-2. Med Oncol (2010) 0.79
Race and insurance status are risk factors for orchiectomy due to testicular trauma. J Urol (2012) 0.79
Increased expression of the androgen receptor with p300 and interleukin-6 coactivators compensate for oligonucleotide suppression of bcl-2: no increased CREB binding protein or interleukin-4 expression. Ther Adv Urol (2013) 0.79
Increased prostate-specific membrane antigen expression in LNCaP cells following treatment with bispecific antisense oligonucleotides directed against bcl-2 and EGFR. Med Oncol (2009) 0.79
Bispecific oligonucleotides may induce interferon expression in LNCaP cells enhancing surface antigen expression: effect of intrastrand base pair complementarity. In Vivo (2011) 0.79
Iatrogenic ureteral injury secondary to a thoracolumbar lateral revision instrumentation and fusion. Spine J (2009) 0.78
Use of resorbable implants for mandibular fixation: a systematic review. J Craniofac Surg (2009) 0.77
Distal ureteral replacement with tubularized porcine small intestine submucosa. Urology (2002) 0.75
Reply by the authors. Urology (2013) 0.75
In LNCaP cells enhanced expression of both androgen receptor and costimulatory protein p300 compensate for antisense oligonucleotide suppression of bcl-2. Ther Adv Urol (2011) 0.75
Compensatory and non-compensatory effects on protein expression following BCL-2 suppression by antisense oligonucleotides. Med Oncol (2011) 0.75
Forgotten ureteral stents: who's at risk? J Endourol (2013) 0.75
Does the prostate retain an endogenous antiviral defense system suggesting a past viral etiology for cancer? Med Hypotheses (2010) 0.75
Images in clinical medicine. Calcifications in a continent urinary diversion. N Engl J Med (2010) 0.75
No compensation in CD44 stem cell marker following BCL-2 suppression by antisense oligonucleotides. In Vivo (2013) 0.75
Oligonucleotide suppression of bcl-2 in LNCaP cells is compensated by increased androgen sensitivity, p53 and oncogene activity, and suppressed caspase-3. Med Oncol (2013) 0.75
A 56-year-old man with a large nonfunctioning adrenal mass. Urology (2009) 0.75
No compensation in VEGF expression follows antisense suppression of BCL-2 activity. In Vivo (2012) 0.75
Genitourinary skin and soft tissue infections: a prospective contemporary evaluation of causative pathogens. J Urol (2013) 0.75
Solitary facial cutaneous metastasis as the primary presentation of a small renal cell carcinoma. Urology (2010) 0.75